FedQuery

Health Research, INC.

UEI G9H6SUM59YC4 · NY · SAM.gov record ↗

$6.9M
FY2025 obligations
13
Contract awards
Jun 28, 2019
First action
Jul 15, 2026
Latest action

Obligations by agency

  • Department Of Health And Human Services$3.6M
  • Social Security Administration$3.3M

Obligations by NAICS

Monthly obligations

Oct 24
Nov 24
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Aug 25
Sep 25
Jan 26
Feb 26
Mar 26
May 26
Jun 26
Jul 26

Contracts ending within 18 months (recompete watch)

  • 28321324P00050051 ↗$2.0M

    NY STATE (NY) - EXERCISE OPTION PERIOD 1 EDR. PERIOD OF PERFORMANCE IS EXTENDED THROUGH DECEMBER 26, 2025. THIS MODIFICATION IS ALSO TO UPDATE THE ALTERNATE COTR, CONTRACTOR'S ADMINISTRATOR, AND DESIGNATION OF GOVERNMENT CONTRACTING PERSONNEL IN

    Ends
    Dec 25, 2026
    Started
    Dec 26, 2023
    Agency
    Social Security Administration
    NAICS
    518210
  • 75D30126P21118 ↗$67K

    2026 NDI EO 14398

    Ends
    Apr 30, 2027
    Started
    Jun 7, 2026
    Agency
    Centers For Disease Control And Prevention
    NAICS
    923120
  • 75D30126F00005 ↗$664K

    NCHS 2026 VSCP

    Ends
    Apr 30, 2027
    Started
    Jan 20, 2026
    Agency
    Centers For Disease Control And Prevention
    NAICS
    518210
  • 28321324P00050206 ↗$1.6M

    NEW YORK STATE EXERCISE OPTION PERIOD 1 EAB RECORDS. THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE THROUGH JUNE 28, 2026, DESIGNATE A NEW COTR, ACOTR, AND UPDATE THE GOVERNMENT CONTRACTING PERSONNEL. THIS MODIFICATION IS ALS

    Ends
    Jun 27, 2027
    Started
    Jun 28, 2024
    Agency
    Social Security Administration
    NAICS
    518210
  • 75N93024C00069 ↗$2.2M

    DESCRIPTION SHOULD HAVE EOI: EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE: LYME DISEASE: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY

    Ends
    Sep 14, 2027
    Started
    Sep 15, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94023F00001 ↗$0

    NICHD: R&D: NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS INFECTION: NON-SEVERABLE

    Ends
    Sep 26, 2027
    Started
    Sep 27, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715

Largest awards

  • 75N93024C00069 ↗$2.2M

    DESCRIPTION SHOULD HAVE EOI: EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE: LYME DISEASE: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY

    Ends
    Sep 14, 2027
    Started
    Sep 15, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 28321324P00050051 ↗$2.0M

    NY STATE (NY) - EXERCISE OPTION PERIOD 1 EDR. PERIOD OF PERFORMANCE IS EXTENDED THROUGH DECEMBER 26, 2025. THIS MODIFICATION IS ALSO TO UPDATE THE ALTERNATE COTR, CONTRACTOR'S ADMINISTRATOR, AND DESIGNATION OF GOVERNMENT CONTRACTING PERSONNEL IN

    Ends
    Dec 25, 2026
    Started
    Dec 26, 2023
    Agency
    Social Security Administration
    NAICS
    518210
  • 28321324P00050206 ↗$1.6M

    NEW YORK STATE EXERCISE OPTION PERIOD 1 EAB RECORDS. THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE THROUGH JUNE 28, 2026, DESIGNATE A NEW COTR, ACOTR, AND UPDATE THE GOVERNMENT CONTRACTING PERSONNEL. THIS MODIFICATION IS ALS

    Ends
    Jun 27, 2027
    Started
    Jun 28, 2024
    Agency
    Social Security Administration
    NAICS
    518210
  • 75D30126F00005 ↗$664K

    NCHS 2026 VSCP

    Ends
    Apr 30, 2027
    Started
    Jan 20, 2026
    Agency
    Centers For Disease Control And Prevention
    NAICS
    518210
  • 75D30125F00004 ↗$664K

    NCHS VSCP NEW YORK STATE

    Ends
    Apr 30, 2026
    Started
    May 13, 2025
    Agency
    Centers For Disease Control And Prevention
    NAICS
    518210
  • 75D30126P21118 ↗$67K

    2026 NDI EO 14398

    Ends
    Apr 30, 2027
    Started
    Jun 7, 2026
    Agency
    Centers For Disease Control And Prevention
    NAICS
    923120
  • 75N94021D00018 ↗$0

    "NEWBORN SCREENING PILOT STUDIES IDIQ"

    Ends
    —
    Started
    Sep 27, 2021
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94022F00001 ↗$0

    NEWBORN SCREENING PILOT STUDIES - CONGENITAL CYTOMEGALOVIRUS (CCMV)

    Ends
    Sep 26, 2025
    Started
    Sep 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94024F00001 ↗$0

    NEWBORN SCREENING PILOT STUDIES: METACHROMATIC LEUKODYSTROPHY (MLD)

    Ends
    Sep 24, 2026
    Started
    Sep 25, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94023F00001 ↗$0

    NICHD: R&D: NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS INFECTION: NON-SEVERABLE

    Ends
    Sep 26, 2027
    Started
    Sep 27, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75D30122F00001 ↗$0

    NCHS VSCP NEW YORK STATE

    Ends
    Apr 30, 2023
    Started
    May 16, 2022
    Agency
    Centers For Disease Control And Prevention
    NAICS
    518210
  • 75N93019C00040 ↗$-5K

    LYME DISEASE: B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION

    Ends
    Sep 14, 2025
    Started
    Sep 15, 2019
    Agency
    National Institutes Of Health
    NAICS
    541713
  • 28321319P00050118 ↗$-230K

    NEW YORK - MODIFICATION TO DE-OBLIGATE $111,880.74 OF THE REMAINING OBLIGATED FUNDS FROM THE ORDER TO CLOSE OUT THE ORDER.

    Ends
    Apr 16, 2025
    Started
    Jun 28, 2019
    Agency
    Social Security Administration
    NAICS
    518210